Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
1.
Arch Med Res ; 53(2): 163-169, 2022 02.
Article in English | MEDLINE | ID: mdl-34384609

ABSTRACT

BACKGROUND: Interleukin (IL)-17A has a dual role in tumor immunity, promotes anti-tumor responses and facilitates angiogenesis by interacting with IL-17 receptor A (IL-17RA). Although IL-17A has been associated with the pathogenesis of papillary thyroid carcinoma (PTC), the nucleotide variability at the IL17A and IL17RA genes is still poorly characterized. AIM: To assess the contribution of the IL17A (-197 G >A, rs2275913) and IL17RA (-947 A >G, rs4819554) single nucleotide polymorphisms (SNP) on the development and progression of PTC and on IL-17 plasma levels. METHODS: We studied 188 PTC patients and 170 healthy controls. SNPs were identified using PCR-amplified DNA and restriction fragment length polymorphism (RFLP) techniques. Plasma levels of IL-17A was evaluated in 83 PTC patients using ELISA. Statistical analyses were performed to evaluate the associations between SNPs and clinicohistopathological features of PTC and IL-17A levels. RESULTS: No significant difference was observed regarding the allele and genotype distributions of both SNPs between PTC patients and controls. The IL17A GA was associated with poor biochemical and structural incomplete response to therapy, whereas no influence over the IL-17A expression was observed. The IL17RA AG was significantly associated with small-sized tumors, initial tumor stage at diagnosis and better response to therapy. CONCLUSIONS: The IL17A SNP may predict an aggressive manifestation of PTC, whereas the IL17RA SNP was associated with a more favorable clinical outcome.


Subject(s)
Interleukin-17 , Thyroid Cancer, Papillary , Thyroid Neoplasms , Case-Control Studies , Genetic Predisposition to Disease , Genotype , Humans , Interleukin-17/genetics , Interleukin-17/metabolism , Polymorphism, Single Nucleotide , Prognosis , Receptors, Interleukin-17/genetics , Thyroid Cancer, Papillary/genetics , Thyroid Neoplasms/genetics
2.
Acta Trop ; 211: 105594, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32598917

ABSTRACT

Congenital toxoplasmosis is a parasitic disease caused by Toxoplasma gondii, an obligate intracellular parasite which can cause fetal death/abortion and can induce damage in the brain and eyes of the infected babies. The environmental and genetic factors associated with T. gondii and the maternal immune response, drive part of the pathogenesis of congenital toxoplasmosis. Thus, in this study, we aimed to investigate the allelic and genotypic frequencies of specific single nucleotide polymorphisms (SNPs) in the IL17A and IL17RA genes, as well as the production of IL-17A, IL-33, and CCL2 in pregnant women, from the State of Rio Grande do Norte, Brazil, further relating these along with the clinical parameters, to the toxoplasmosis infection. Through PCR-RFLP techniques, two SNPs implicated in Th17 immune response, IL17A rs2275913 (G> A) and IL17RA rs4819554 (A> G) modulation were evaluated in pregnant women, either infected or not infected by T. gondii. These women were also evaluated in terms of plasma release of CCL2, IL-33, and IL-17A which relate to hypertension, number of abortions, and ethnic pattern. The results showed that the G-allele of the SNP rs2275913 (IL17A) appeared to be protective in this population, while the rs4819554 (IL17RA) SNP G allele was associated with greater susceptibility to T. gondii infection [ρ value = 0.025; OR = 2.815 (1.118-7.089); CI = 95%]. None of the cytokines had any influence on the analyzed parameters (abortion and hypertension). In conclusion, our data suggest an immunogenic evidence of susceptibility to T. gondii infection driven by the rs4819554 (IL17RA) SNP G allele in Brazilian pregnant women. Further studies are needed to reinforce this trial marker in populations from distinct geographical areas as well as to confirm the protective pattern related to the G-allele of the SNP rs2275913 (IL17A) in pregnant women.


Subject(s)
Genetic Predisposition to Disease , Pregnancy Complications, Parasitic/genetics , Receptors, Interleukin-17/metabolism , Toxoplasmosis/genetics , Adult , Antibodies, Protozoan/blood , Brazil/epidemiology , Cytokines/genetics , Female , Genotype , Humans , Polymorphism, Single Nucleotide , Pregnancy , Pregnancy Complications, Parasitic/epidemiology , Pregnant Women , Receptors, Interleukin-17/genetics , Toxoplasma/immunology , Young Adult
3.
Viral Immunol ; 28(6): 339-42, 2015.
Article in English | MEDLINE | ID: mdl-25965646

ABSTRACT

The objective of this work was to evaluate the influence of human papillomavirus (HPV) vaccination on peripheral blood mononuclear cell (PBMC) proliferation and cytokine gene transcription. PBMCs isolated after HPV immunization were incubated with HPV vaccine, phytohemagglutinin, or buffer. Cell proliferation was assessed by MTT reduction assay. RNA was extracted from PBMCs, and the relative concentration of cytokine messenger RNA (mRNA) transcripts (IFN-ß, IFN-γ, IL-12, TNF-α, IL-6, IL-17, or IL-10) relative to transcription of the ß-actin gene was determined by real-time polymerase chain reaction. PBMC proliferation in response to HPV vaccine and PHA were greater than that observed in unstimulated cells (p<0.001). Cytokine mRNAs were upregulated in stimulated PBMC cultures. The median increase in vaccine-stimulated cultures was: IFN-ß=334.4-fold; IL-12=46.33-fold; IFN-γ=12.64-fold; IL-6=9.07-fold; IL-17=7.33-fold; IL-10=6.47-fold; and TNF-α=2.36-fold. The IFN-ß expression was significantly higher (p<0.05). Proliferative PBMC responses and multiple cytokine gene expression were detected in women who received the HPV vaccine.


Subject(s)
Cytokines/biosynthesis , Gene Expression Profiling , Leukocytes, Mononuclear/immunology , Papillomavirus Vaccines/immunology , RNA, Messenger/analysis , Cell Proliferation , Cytokines/genetics , Female , Humans , Oxidation-Reduction , Papillomaviridae , Papillomavirus Vaccines/administration & dosage , Real-Time Polymerase Chain Reaction , Tetrazolium Salts/metabolism , Thiazoles/metabolism
4.
Acta cir. bras ; 19(3): 267-275, May-June 2004. graf
Article in Portuguese | LILACS | ID: lil-362030

ABSTRACT

OBJETIVO: Neste trabalho avaliou-se a ação da glucana b ® 1-3 insolúvel, um polissacarídeo extraído da parede celular interna do fungo Saccharomyces cerevisae, como agente imunoestimulante inespecífico em camundongos submetidos a modelo de sepse experimental. MÉTODOS: Foram utilizados 73 camundongos Swiss, os quais receberam glucana em diferentes doses pelas vias intraperitoneal (i.p.). Sepse difusa foi induzida através da técnica de ligadura e punção do ceco, transfixado e drenado com fio multifilamentar. RESULTADOS: Os animais tratados com glucana apresentaram um aumento significante no número de leucócitos no lavado peritoneal, diminuição no número de unidades formadoras de colônias bacterianas. Observou-se um aumento significante na sobrevida dos animais tratados com glucana insolúvel, a qual proporcionou um maior controle da infecção bacteriana por aumentar o número de células de defesa. CONCLUSAO: A glucana insolúvel, quando usada em camundongos por via intraperitoneal, em modelo de sepse abdominal, contribuiu para melhorar a sobrevida, induziu proteção contra a formação de colônias bacterianas no líquido peritoneal e aumentou a migração leucocitária.


Subject(s)
Animals , Male , Female , Mice , Bacterial Infections , Glucans , Leukocytes , Sepsis , Survival Analysis , Saccharomyces cerevisiae
SELECTION OF CITATIONS
SEARCH DETAIL
...